Hims & Hers Health Inc - Class A
NYSE: HIMS
$51.85
+$1.39 (+2.75%)
Closing Price on July 16, 2025
HIMS Stock Chart and Intraday Price
HIMS Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Address | 333 S. GRAND AVE., 28TH FLOOR, LOS ANGELES, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 2,810.96M USD |
| Shares Outstanding | 205,873,000 |
HIMS Articles
Digging Into the Bargain Bin Investing in beaten-down stocks can be a savvy strategy for long-term wealth creation, as it allows investors to buy high-quality companies at bargain prices. When market...
Published:
If you wish to turn $10,000 into $50,000 by 2035, you’re looking at a 400% gain over a 10-year horizon. In the past decade, the S&P 500 has gained 194%, and the Nasdaq has gained 312%. The past...
Published:
The Power of Long-Term Investing Long-term investing is the cornerstone of wealth creation, prioritizing steady growth over fleeting market spikes. Before buying stocks, investors should go into it...
Published:
Investors usually focus on stocks that already have stellar dividend yields, but your portfolio could also benefit from dividend growers. There are companies with solid fundamentals with a history of...
Published:
There’s a well-known saying in the investing world, which advises investors to “sell in May and go away.” Historically, that has been solid advice, based on the typical seasonality of markets...
Published:
Hims & Hers Health (NYSE:HIMS) reported a strong financial performance for Q1 2025, with revenue reaching $586 million, marking a 111% increase year-over-year. The company achieved a net income...
Published:
Live Updates Live Coverage Has Ended HIMS forward guidance is exciting 5:02 pm by Joel South HOLY MOLY $HIMS JUST GUIDED TO $6.5B IN 2030 SALES WITH 20% EBITDA MARGINS 😳 pic.twitter.com/9w2fDU8rlQ...
Published:
Live Updates Live Coverage Has Ended S&P 500 Extends Its Winning Streak 4:18 pm The S&P 500 closed up 0.6% for Tuesday, extending its winning streak to six straight days. Trade Talks Keep...
Published:
Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to...
Published:
Live Updates Live Coverage Has Ended S&P's Losing Streak, Mag 7 Correction 3:29 pm by Gerelyn Terzo The markets remain under pressure as of mid-afternoon, with the exception of the Dow Jones...
Published:
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was over. It said the Danish pharmaceutical had sufficient supply of its...
Published:
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. About This Article Just this morning, the US FDA said Novo Nordisk’s popular...
Published:
Live Updates Live Coverage Has Ended Quantum Leap 3:39 pm by Gerelyn Terzo Stocks have managed to find their way into positive territory as of late afternoon. The Fed is looking for further inflation...
Published:
Stock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating inflation to rise in 2025, potentially depressing consumer spending and dissuading...
Published:
Last Updated:
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly (NYSE:LLY) has become the industry leader in a class of drugs called...
Published: